Pharma News

Sanofi announced on January 9 that its CD38 monoclonal antibody isatuximab injection has been approved for sale in China. This medication will be used in combination with pomalidomide and dexamethasone to treat adult patients with multiple myeloma (MM) wh

Novo Nordisk announced on January 8 that it has reached an expansion agreement with Valo Health, aiming to leverage Valo's extensive human datasets and AI-driven computational capabilities to discover and develop new treatments for obesity, type 2 diabete

Alloy Therapeutics announced a specific target collaboration and licensing agreement with Sanofi focused on central nervous system (CNS) targets. This agreement involves Alloy's innovative and proprietary AntiClastic Antisense platform. Sanofi will levera

On January 6, 2025, the Hong Kong Stock Exchange (HKEX) announced on its official website that Hengrui Medicine has submitted a listing application to the HKEX. The joint sponsors for this listing application are Morgan Stanley, Citi, and Huatai Internati

Recently, the National Medical Products Administration announced an important decision to stop the production, sale, and use of Hyoscine Butylbromide Tablets, and to revoke its drug registration certificate. According to the announcement issued by the Nat

The National Medical Products Administration has approved several new indications for the Gardasil vaccine (quadrivalent human papillomavirus vaccine, yeast-derived) by Merck & Co., suitable for males aged 9 to 26. This approval makes Gardasil the first a

PwC's recently released report, "The Weight Loss Industry: How Weight Loss Drugs Will Disrupt the Consumer Sector," points out that the food and beverage industry will face significant impacts from GLP-1 weight loss drugs. The report is based on a survey

According to the official announcement from the National Medical Products Administration (NMPA), Platinum Biotechnology (Beijing) Co., Ltd. has received conditional approval for its stem cell therapy "Aimi Mitosai," which is used to treat acute graft-vers

The drug is suitable for the following two categories of adult patients: first, those with type 2 diabetes who, despite receiving treatment with metformin and/or sulfonylureas, still have unsatisfactory blood sugar control based on diet control and exerci

HuaLing Pharma (02552.HK) announced new progress in building its sales team at the beginning of 2025. On January 1, the company announced the appointment of Lu Yu as Vice President of Sales and Marketing.

Hutchison China MediTech Limited announced on January 1 that it has reached two agreements to sell 45% of its equity in Shanghai Hutchison Pharmaceuticals for $608 million (approximately 44.78 billion yuan) in cash to Shanghai Jinfeng Health Investment Ma

WuXi AppTec Biologics announced on Monday that it has agreed to sell its vaccine plant in Ireland to U.S. pharmaceutical giant Merck & Co. for approximately $500 million. This move comes after the U.S. House of Representatives passed the Biosecure Act, wh

The U.S. Court of Appeals for the Second Circuit has reinstated the lawsuit against Novartis. The plaintiff is Steven Camburn, a former sales representative for Novartis, who alleges that the company illegally paid kickbacks to doctors to promote its mult

China has launched a national program aimed at addressing the rising incidence of dementia. Relevant departments point out that dementia has become a widespread social issue and poses a significant challenge to the well-being of the elderly and their fami

On December 30, 2024, Yuekang Pharmaceutical issued a statement responding to the recent report from the National Medical Insurance Bureau regarding the "one drug, dual price" incident concerning ginkgo leaf extract injection. The company explicitly state

As 2025 approaches, Gilead has welcomed an exciting start. The latest announcement from the official website of the National Medical Products Administration (NMPA) in China has confirmed that Gilead's application for marketing approval for its new 5.1 cla

According to information from the CDE website, GlaxoSmithKline (GSK) has submitted a marketing application for depemokimab in China. Considering the latest progress in clinical trials, the expected indication for this drug is severe eosinophilic asthma (S

According to an analysis by 3 Axis Advisors, American pharmaceutical companies plan to raise the prices of at least 250 brand-name drugs in early 2025. These drugs include Pfizer's COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer treatment drugs

At a routine press conference on Tuesday, Chinese Foreign Ministry spokesperson Mao Ning stated that China is the country that shares the most COVID-19 data and research results with the international community. Mao pointed out that China has not only org

The UK Medicines and Healthcare products Regulatory Agency (MHRA) announced on Tuesday the approval of a new drug developed by Merck for the treatment of a rare lung disease. This approval further solidifies the pharmaceutical company’s success in the pot